Leon-Nanodrugs Appoints CEO
This article was originally published in Scrip
Leon-Nanodrugs, a nanotechnology-based drug development company, has named Theron Odlaug CEO of Leon-Nanodrugs GmbH. in Germany and Leon-Nanodrugs, Inc in the US. Odlaug has more than 35 years of experience in the biopharmaceutical industry and joins Leon-Nanodrugs from Cedarburg Pharmaceuticals where he was executive chair. Previously, he was the executive chair and CEO of Planet Biopharmaceuticals and CEO of CyDex Pharmaceuticals, Inc.